Eight-week ledipasvir/sofosbuvir in non-cirrhotic, treatment-naïve hepatitis C genotype-1 patients with hepatitis C virus-RNA < 6 million: Single center, real world effectiveness and safety

AIM: To evaluate sustained viral response (SVR) of 8-wk ledipasvir/sofosbuvir therapy among non-cirrhotic, genotype-1 hepatitis C virus (HCV) patients with RNA < 6 million IU/mL. METHODS: We performed a retrospective cohort study to examine SVR rates, predictors of treatment failure and safety an...

Descripción completa

Detalles Bibliográficos
Autores principales: Latt, Nyan L, Yanny, Beshoy T, Gharibian, Derenik, Gevorkyan, Rita, Sahota, Amandeep K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514641/
https://www.ncbi.nlm.nih.gov/pubmed/28765697
http://dx.doi.org/10.3748/wjg.v23.i26.4759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514641/
https://www.ncbi.nlm.nih.gov/pubmed/28765697
http://dx.doi.org/10.3748/wjg.v23.i26.4759

Ejemplares similares